1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Portugal Pharmaceuticals and Healthcare Report Q4 2015

Portugal Pharmaceuticals and Healthcare Report Q4 2015

  • October 2015
  • -
  • Business Monitor International
  • -
  • 104 pages

BMI View: Despite sustained economic growth and buoyant consumption indicators, high public andprivate debt levels in Portugal will remain a significant drag on the country's attractiveness topharmaceutical companies. While hospital debt levels and payment delays have declined in 2015,the ongoing inability of public hospitals to manage their finances is still a cause for concern. Meanwhile,although we forecast the next government administration to take office after October 2015 to embark on anexpansionary fiscal trajectory, Portugal's public sector debt burden will act as a major constraint on amore robust fiscal expansion, hindering repayments to drugmakers and the creation of a more sustainable,long-term payment facility by public hospitals.

Headline Expenditure Projections
- Pharmaceuticals: EUR3.25bn (USD4.36bn) in 2014 to EUR3.11bn (USD3.43) in 2015; -4.2% in localcurrency and -21.3% in US dollar terms. Forecast broadly in line with the last quarter in local currencyterms and US dollar terms.

Table Of Contents

Portugal Pharmaceuticals and Healthcare Report Q4 2015
BMI Industry View 7
SWOT 9
Political 11
Economic 12
Operational Risk 13
Industry Forecast 14
Pharmaceutical Market Forecast 14
Table: Pharmaceutical Sales, Historical Data And Forecasts (Portugal 2011-2019) 16
Healthcare Market Forecast 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Portugal 2011-2019) 20
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts 20
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts 20
Prescription Drug Market Forecast 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Portugal 2011-2019) 22
Patented Drug Market Forecast 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Portugal 2011-2019) 25
Generic Drug Market Forecast 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Portugal 2011-2019) 28
Table: Top Generic Drugs By Value In 2011 28
Table: Average Price Of Top Generic Drugs By Value 2010-2011 29
OTC Medicines Market Forecast 30
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Portugal 2011-2019) 32
Table: OTC Sales Outside Of Pharmacies By Therapeutic Group (Jan-Sep 2012) 33
Table: OTC Sales Outside Of Pharmacies By District (Jan-Sep 2012) 33
Table: OTC Sales Outside Of Pharmacies By Sales Outlet (Jan-Sep 2012) 34
Table: Portugal OTC Sales Outside Of Pharmacies By Active Ingredient (Jan-Sep 2012) 34
Pharmaceutical Trade Forecast 35
Table: Pharmaceutical Trade Data And Forecasts (Portugal 2013-2019) 38
Table: Pharmaceutical Trade Data And Forecasts local currency (Portugal 2013-2019) 38
Key Risks To BMI's Forecast Scenario 39
Macroeconomic Forecasts 40
Economic Analysis 40
Table: Economic Activity (Portugal 2010-2019) 43
Industry Risk Reward Index 44
Western Europe Risk/Reward Index 44
Portugal Risk/Reward Index 49
Rewards 49
Risks 50
Market Overview 51
Industry Trends And Developments 52
Epidemiology 52
Healthcare System 54
Hospital Infrastructure And Services 55
Outpatient Infrastructure And Services 57
Table: Healthcare Resources (Portugal 2009-2014) 57
Table: Healthcare Personnel (Portugal 2009-2014) 58
Table: Healthcare Activity (Portugal 2009-2014) 58
Clinical Trials 58
Regulatory Development 60
Regulatory Regime 60
Parallel Imports 62
Intellectual Property Issues 66
Pricing Regime 66
Reimbursement Regime 70
Pharmacoeconomics 71
Competitive Landscape 72
Research-Based Industry 72
Generic Drugmakers 73
Recent Developments 73
Pharmaceutical Distribution 74
Pharmaceutical Retail Sector 74
Table: Number Of Pharmaceutical Companies, Wholesalers, Pharmacies, Pharmacy Extensions And Drug Stores In Portugal 78
Company Profile 79
Hovione 79
Bial 83
Medinfar 87
Bluepharma 90
Demographic Forecast 93
Table: Population Headline Indicators (Portugal 1990-2025) 94
Table: Key Population Ratios (Portugal 1990-2025) 94
Table: Urban/Rural Population and Life Expectancy (Portugal 1990-2025) 95
Table: Population By Age Group (Portugal 1990-2025) 95
Table: Population By Age Group % (Portugal 1990-2025) 96
Glossary 98
Methodology 100
Pharmaceutical Expenditure Forecast Model 100
Healthcare Expenditure Forecast Model 100
Notes On Methodology 101
Risk/Reward Index Methodology 102
Index Overview 103
Table: Pharmaceutical Risk/Reward Index Indicators 103
Indicator Weightings 104

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.